Julie Sawyer Montgomery, Executive Vice President at Danaher Corp.

About

Sawyer Montgomery serves as an Executive Vice President of Danaher and is a named executive officer who has assumed a segment leadership role. Her 2025 personal performance objectives included cost reductions, revenue, quality, talent development and sustainability, along with innovation and AI, and in 2025 she received a special equity grant with a target value of $5 million.

Roles

Danaher Corp.

Executive Vice President · Current role

2024–present

Danaher Corporation (Diagnostics)

Vice President – Group Executive

January 2023 – June 2024

Beckman Coulter Diagnostics

President · A Danaher subsidiary.

January 2020 – December 2022

Danaher Corporation (Beckman Coulter Diagnostics)

Joined Danaher; roles of increasing responsibility in commercial operations and R&D, then President of Beckman Coulter Diagnostics · Per Danaher's official leadership bio.

2017 – 2022

Hospira Infusion Systems

Leadership roles · Held prior to joining Danaher, per the official bio.

—

Boston Scientific

Leadership roles · Held prior to joining Danaher, per the official bio.

—

Boston Consulting Group

Leadership roles · Held prior to joining Danaher, per the official bio.

—